11 post(s) tagged "Camillo Ricordi"
Diabetes Research Institute Announces Breakthrough Transplantation Approach for the Treatment of Type 1 Diabetes at ADA 2024
June 21, 2024 | Reading Time: 5 min.
Miller School Researchers Enter Phase 3 of Stem Cell Clinical Trial in Treating COVID-19 Acute Respiratory Distress Syndrome
August 25, 2021 | Reading Time: 3 min.
Diabetes Research Institute Launches Trial of Novel Investigational Treatment for Type 1 Diabetes
April 12, 2021 | Reading Time: 3 min.
Miller School Leads Groundbreaking Trial Treating Severe COVID-19 with Mesenchymal Stem Cells
January 05, 2021 | Reading Time: 8 min.
New Cell Therapy Trial Launches for Patients with Severe COVID-19
April 15, 2020 | Reading Time: 2 min.
FDA Gives Orphan Status for Potential Type 1 ‘Brittle’ Diabetes Therapy
May 28, 2019 | Reading Time: 3 min.
Diabetes Researcher Explores New Strategies to Treat Autoimmune Diseases
April 24, 2019 | Reading Time: 3 min.
Diabetes Research Institute Director Camillo Ricordi, M.D., Appointed to Italy’s Supreme Council of Health
March 19, 2019 | Reading Time: 3 min.